<DOC>
	<DOCNO>NCT02656368</DOCNO>
	<brief_summary>SEBORRHEAMEDIS Face Cream barrier-based , non-steroidal cream . The cream include plant extract The cream design manage symptom facial Seborrheic dermatitis symptom erythema , scale pruritus .</brief_summary>
	<brief_title>Safety Efficacy SEBORRHEAMEDIS Face Cream Patients With Seborrheic Dermatitis</brief_title>
	<detailed_description>30 subject enrol study . After eligibility confirm , subject ask sign Informed Consent form . At baseline visit , investigator select target area face . The target area evaluate erythema ( redness ) desquamation ( scale ) use 5-point scale : 0 = none , 1 = minimal , 2 = mild , 3 = moderate 4 = severe . Photography target area take . For reference , fix object ( ruler ) photograph frame . In addition , investigator ass overall facial lesion use ISGA base 5-point scale . The subject evaluate his/her pruritis past 24 hour , use 5-point scale : 0 = itching , 1 = minimal rare itching , 2= mild itching , ( subject aware itch relaxed ) , 3= moderate itching ( subject often aware itch , occasionally disturbs sleep ) , 4 = severe constant itching . Subjects instruct use SEBORRHEAMEDIS Face Cream twice day , morning evening , consecutive period 42 day . In addition baseline visit ( day 0 ) , subject ask come clinic two follow-up visit day 14 28 final visit day 42 . A flexibility Â±2 day allow . In case adverse event , subject ask immediately contact clinic , come unscheduled visit need . At two follow-up visit final visit , investigator evaluate overall severity seborrhea ( ISGA ) target area 's erythema desquamation . The subject ass his/her pruritus past 24 hour . At final visit , subject also complete product-assessment questionnaire . The questionnaire ask several question satisfaction attribute , use 5-point scale : -2 = unsatisfied , -1 = unsatisfied , 0 = neutral , +1 = satisfy , +2 = satisfy . Attributes include : overall satisfaction , speed result , ease use , ease spread , comfort makeup , feel skin ( -2 = greasy , +2 = moisturize ) , speed absorption , texture , color odor</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Seborrheic</mesh_term>
	<criteria>Subject mild ( ISGA=2 ) moderate ( ISGA=3 ) facial Seborrheic dermatitis . Male female age 18 year old . Subject agree use Seborrheic Dermatitis medication study , except test product . Subject willing sign Informed Consent Subject pregnant lactating . Subject condition require continuous systemic topical corticosteroid antimycotic therapy Subject severe disease likely interfere study conduct Subject know sensitivity ingredient contain tested product . Subject expect extensively expose sun study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>